AVITA Medical, Inc. (RCEL) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $10.24M | -27.1% |
| 2024 | $14.05M | -36.5% |
| 2023 | $22.12M | +21.8% |
| 2022 | $18.16M | -67.3% |
| 2021 | $55.51M | -24.6% |
| 2020 | $73.64M | +265.0% |
| 2019 | $20.17M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $10.24M | -27.1% |
| 2024 | $14.05M | -36.5% |
| 2023 | $22.12M | +21.8% |
| 2022 | $18.16M | -67.3% |
| 2021 | $55.51M | -24.6% |
| 2020 | $73.64M | +265.0% |
| 2019 | $20.17M | — |